<DOC>
	<DOCNO>NCT00352417</DOCNO>
	<brief_summary>This study compare effect VIA-2291 v . Placebo various inflammatory biomarkers patient carotid stenosis schedule elective carotid endarterectomy</brief_summary>
	<brief_title>Study Effect VIA-2291 Atherosclerotic Vascular Inflammation Patients Undergoing Elective Carotid Endarterectomy</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Lipoxygenase Inhibitors</mesh_term>
	<mesh_term>Atreleuton</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Female patient must nonchildbearing potential Carotid stenosis 60 % 90 % schedule CEA surgery One follow clinical feature : Prior history &gt; 4 week cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) consistent North American Symptomatic Carotid Endarterectomy Trial ( NASCET ) criteria prior history amaurosis fugax occur time Diabetes haemoglobin ( Hb ) A1c 7.0 11 % history two fast blood glucose level &gt; 6.9 mmol/L Baseline hsCRP &gt; 2 mg/L Echolucent plaque Acute CVA TIA within 4 week enrollment presence ulcerate unstable plaque require urgent carotid endarterectomy Renal insufficiency define creatinine &gt; 1.5 x upper limit normal ( ULN ) Cirrhosis , recent hepatitis , alanine aminotransferase ( ALT ) &gt; 1 x ULN ( i.e. , normal range ) positive screen test hepatitis B ( hepatitis B surface antigen ) hepatitis C ( ELISA ) Uncontrolled diabetes mellitus within 1 month prior study screening , define HbA1c &gt; 11 % screen Congestive heart failure ( CHF ) define New York Heart Association functional Class III IV Recent acute coronary syndrome event coronary artery bypass graft ( CABG ) surgery ( within 4 week enrollment ) Current atrial fibrillation Planned cardiac intervention Acetaminophen use form 7 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>